BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26446011)

  • 21. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
    Seven M; Shah LL; Daack-Hirsch S; Yazici H
    Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
    Chopra I; Kelly KM
    J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What women with breast cancer discuss with clinicians about risk for their adolescent daughters.
    Maloney E; Edgerson S; Robson M; Offit K; Brown R; Bylund C; Kissane DW
    J Psychosoc Oncol; 2012; 30(4):484-502. PubMed ID: 22747109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
    Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
    Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
    Peshkin BN; Schwartz MD; Isaacs C; Hughes C; Main D; Lerman C
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1115-8. PubMed ID: 12376518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.
    Dancyger C; Wiseman M; Jacobs C; Smith JA; Wallace M; Michie S
    Psychol Health; 2011 Aug; 26(8):1018-35. PubMed ID: 21797732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
    Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
    Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intention to communicate BRCA1/BRCA2 genetic test results to the family.
    Barsevick AM; Montgomery SV; Ruth K; Ross EA; Egleston BL; Bingler R; Malick J; Miller SM; Cescon TP; Daly MB
    J Fam Psychol; 2008 Apr; 22(2):303-12. PubMed ID: 18410217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
    Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
    J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.
    Conley CC; Ketcher D; Reblin M; Kasting ML; Cragun D; Kim J; Ashing KT; Knott CL; Hughes-Halbert C; Pal T; Vadaparampil ST
    J Genet Couns; 2020 Jun; 29(3):410-422. PubMed ID: 31912597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
    Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
    Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
    Foster C; Evans DG; Eeles R; Eccles D; Ashley S; Brooks L; Cole T; Cook J; Davidson R; Gregory H; Mackay J; Morrison PJ; Watson M
    Genet Test; 2004; 8(1):23-9. PubMed ID: 15140371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
    Vos J; Oosterwijk JC; Gómez-García E; Menko FH; Jansen AM; Stoel RD; van Asperen CJ; Tibben A; Stiggelbout AM
    Clin Genet; 2011 Mar; 79(3):207-18. PubMed ID: 21114486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
    Nelson HD; Pappas M; Zakher B; Mitchell JP; Okinaka-Hu L; Fu R
    Ann Intern Med; 2014 Feb; 160(4):255-66. PubMed ID: 24366442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
    Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.